Want to join the conversation?
Excluding CEO transition costs of $19.69MM in 3Q14, general and administrative expenses as a percentage of consolidated revenue for 3Q15 were 3.77% vs. 3.63% last year. The increase was mainly related to costs associated with $HCN's initiatives to attract and retain appropriate personnel to achieve its business objectives.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?